Study may ease Rita's entry in bone cancer pain market
This article was originally published in Clinica
Executive Summary
Rita Medical Systems' plans to market its radiofrequency (RF) ablation technology for the treatment of pain caused by metastatic bone cancer were booted last week, following the release of positive trial data.